| 发明名称 |
Pharmaceutical compositions |
| 摘要 |
The invention concerns a pharmaceutical composition comprising the HMG CoA reductase inhibitor (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof as the active ingredient, which remains stable over a prolonged period.
|
| 申请公布号 |
US6316460(B1) |
申请公布日期 |
2001.11.13 |
| 申请号 |
US20000633064 |
申请日期 |
2000.08.04 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
CREEKMORE JOSEPH R;WIGGINS NORMAN A. |
| 分类号 |
C07D239/42;A61K9/14;A61K9/20;A61K9/22;A61K31/505;A61K47/02;A61K47/04;A61K47/14;A61K47/26;A61K47/38;A61P3/00;A61P3/06;A61P9/10;A61P19/00;A61P43/00;(IPC1-7):A61K31/505;A61K31/19 |
主分类号 |
C07D239/42 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
